Biostimulants in plant brassinosteroid hormone receptor BRI1 activation—a new system to evaluate activation capacity
The FEBS Journal · 2026
DOI: 10.1111/febs.70235 ↗Kurz gefasst
Fachartikel in der Zeitschrift The FEBS Journal, 2026. Verfasst von Maribel Marquina und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Science, University of Barcelona, Spain. Hauptthemen laut MEDLINE: Arabidopsis Proteins, Brassinosteroids, Arabidopsis, Steroids, Heterocyclic. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya, Ministerio de Ciencia y Tecnología.
Abstract (Originalsprache)
The search for innovative and alternative chemical methods to manage plant growth is an ever‐increasing reality. Biostimulants, products of biological origin, have shown promise in improving various agronomic characteristics and boosting yield. However, the selection and characterization of biostimulant matrices is a complex process that requires rigorous evaluation adapted to the specific needs of each plant. Because mixtures of biologically active compounds are present in biostimulants, efficient methods are required to characterize their potential mode of action. In this study, a new approach was developed to assess the biological activity of biostimulants by activating specific plant receptors involved in key physiological processes. It is based on the heterologous expression in fission yeast of brassinosteroid receptor protein Brassinosteroid Insensitive 1 (BRI1), which is involved in plant growth and development, and its specific activation by brassinolide (BL). The method involves the identification of highly expressed genes in response to BL activation of the BRI1 receptor, to generate a GFP reporter gene system that is switched on when biostimulants activate the BRI1 receptor. The biostimulants selected for testing were hydrolysates of animal origin. The results not only revealed variations in BRI1 activation among biostimulants, but also highlighted that samples from the same origin exhibit different BRI1 activation capacities depending on their processing methods. This new method enables direct classification of the mode of action of biostimulants by assessing their ability to activate specific plant receptors, providing a valuable resource for biostimulant research and development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Science, University of Barcelona, Spain.
- Biosanitary Research Institute, Valencian International University (VIU), Valencia, Spain.
- Department of Biosciences, Faculty of Mathematics and Natural Sciences, University of Oslo, Norway.
- Departamento de I+D+i de Fertinagro Biotech S.L, Poligono Industrial La Paz, Teruel, Spain.
ORCID-Profile: Rosa Aligué
Förderung
- Departament d'Innovació, Universitats i Empresa, Generalitat de Catalunya
- Ministerio de Ciencia y Tecnología
Zitieren
APA
Marquina, M., Ricart-Fort, M., Díaz-Parra, R., López-Avilés, S., Yance, T., Quirós, P., Contreras, E., Salaet, I., Atares, S., & Aligué, R. (2026). Biostimulants in plant brassinosteroid hormone receptor BRI1 activation—a new system to evaluate activation capacity. The FEBS Journal. https://doi.org/10.1111/febs.70235
Vancouver
Marquina M, Ricart-Fort M, Díaz-Parra R, López-Avilés S, Yance T, Quirós P, et al. Biostimulants in plant brassinosteroid hormone receptor BRI1 activation—a new system to evaluate activation capacity. The FEBS Journal. 2026. doi:10.1111/febs.70235
BibTeX
@article{Marquina2026,
author = {Marquina, Maribel and Ricart-Fort, Montserrat and Díaz-Parra, Rocío and López-Avilés, Sandra and Yance, Tula and Quirós, Pablo and Contreras, Elena and Salaet, Ignasi and Atares, Sergio and Aligué, Rosa},
title = {Biostimulants in plant brassinosteroid hormone receptor BRI1 activation—a new system to evaluate activation capacity},
journal = {The FEBS Journal},
year = {2026},
doi = {10.1111/febs.70235}
}
EUVIMED